About Dongwha Pharm
Dongwha Pharm is a company based in Seoul (South Korea) founded in 1897. The company has 824 employees as of December 31, 2024. Dongwha Pharm offers products and services including Pharmaceutical Drugs and Health Supplements.
- Headquarter Seoul, South Korea
- Employees 824 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dong Wha Pharm Co., Ltd.
-
Annual Revenue
$315.18 M (USD)28.74as on Dec 31, 2024
-
Net Profit
$3.77 M (USD)-79.72as on Dec 31, 2024
-
EBITDA
$22.41 M (USD)3.98as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
824
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Dongwha Pharm
Dongwha Pharm is a publicly listed company on the KRX with ticker symbol 000020 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Dongwha Pharm
Dongwha Pharm offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs and Health Supplements.
Manufacturing and selling of drugs for medical treatments is carried out by the company
Distribution of supplements for health maintenance is performed by the company
Funding Insights of Dongwha Pharm
Detailed funding history for Dongwha Pharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dongwha Pharm
Investment portfolio details for Dongwha Pharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dongwha Pharm
Detailed financials for Dongwha Pharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dongwha Pharm Comparisons
Peer comparison for Dongwha Pharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dongwha Pharm
Detailed competitors of Dongwha Pharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dongwha Pharm
Complete news archive for Dongwha Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dongwha Pharm
Dongwha Pharm was founded in 1897.
Dongwha Pharm is headquartered in Seoul, South Korea.
As of Dec 31, 2024, the latest employee count at Dongwha Pharm is 824.
Annual revenue of Dongwha Pharm is $315.18M as on Dec 31, 2024.
Dongwha Pharm was founded in 1897 in Seoul, South Korea, and operates within the pharmaceutical sector. Ethical drugs are produced, covering gastrointestinal agents, antibiotics, circulatory remedies, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies, genitourinary remedies, and anticancer agents. Over-the-counter drugs are also manufactured, including cold remedies, dental remedies, hepatic protectors, nutrients, tonics, topical analgesics, and anti-smoking agents. Pharmaceutical ingredients and healthcare food and drinks are provided additionally.
Dongwha Pharm offers Pharmaceutical Drugs and Health Supplements.
Yes, Dongwha Pharm is publicly traded on KRX under the ticker symbol 000020.
The ticker symbol of Dongwha Pharm is 000020 on KRX.